RE:RE:The delay to close the last PP.ScienceFirst wrote But it could also more and more sounds like a "Ok. Can we talk about jv plans before you close your pp?" from a big pharma and that due diligence/discussions are ongoing, which would explain the current delay. Remember also that we have NML input expected somewhere in Q4.
We'll see.
Interesting though ScienceFirst, I think in my opinion it would be a "no" for the reason that neither a financial raise or JV discussion would affect the others closing. I do agree that advancement in NML could however could be announced very soon. My thoughts on the closing delay is it could be nothing out of the ordinary and nothing to be concerned about, it will happen when it happens.